Should we give triple therapy to patients with atrial fibrillation after percutaneous intervention?

[摘要] No. In patients with atrial fibrillation undergoing percutaneous coronary intervention (PCI), the combination of an anticoagulant plus 2 antiplatelet drugs (“triple therapy”) has been shown to lead to more bleeding events and a higher mortality rate than anticoagulation plus a single antiplatelet drug (“double therapy”).

[学科分类] 卫生学